Skip to content

Coronary Artery Disease Reference

Coronary artery disease is reduced delivery of oxygen-rich blood to the heart muscle because one or more coronary arteries have narrowed or become obstructed. Atherosclerosis—the accumulation and inflammatory change of plaque within artery walls—is the most common cause. CAD can be obstructive or nonobstructive, and dysfunction in the heart’s smaller vessels can produce coronary microvascular disease even when the major arteries do not contain a severe focal blockage.

CAD is chronic, but its course is not uniformly gradual. A person may have stable symptoms for years, experience symptoms only with exertion, have disease discovered during risk assessment, or first come to medical attention during an acute coronary syndrome. A plaque can rupture and trigger a clot that suddenly interrupts blood flow even when a previous narrowing was not complete.

Coronary Blood Flow and Terminology

The coronary arteries supply the myocardium, the muscle that performs the heart’s pumping work. When oxygen demand exceeds the blood supply, ischemia can cause angina or other symptoms. Prolonged loss of blood flow can injure or kill heart muscle, producing a myocardial infarction.

The left anterior descending artery, or LAD, supplies a large portion of the left ventricle and the interventricular septum. ‘’Widowmaker’’ is an informal term most often used for a severe or complete blockage high in the LAD because the amount of threatened heart muscle can make the event rapidly fatal. It is not a separate diagnosis, and neither every LAD lesion nor every complete coronary occlusion has the same anatomy, presentation, or outcome.

CAD, myocardial infarction, and cardiac arrest are related but distinct. CAD is the underlying coronary condition. A myocardial infarction is acute heart-muscle injury caused by ischemia, most often after a clot forms at a disrupted plaque. Cardiac arrest is the loss of effective cardiac pumping, usually because of a lethal rhythm; an infarction can cause arrest, but the terms are not interchangeable.

Causes and Risk

Atherosclerotic CAD develops through interacting biological and social conditions rather than a single habit or personality trait. Established risk factors include high blood pressure, high LDL cholesterol, diabetes, tobacco exposure, increasing age, kidney disease, and a family history of early heart disease. Sleep apnea, chronic inflammatory conditions, limited access to preventive care, medication cost, occupational exposures, night-shift work, chronic stress, and exposure to racism or violence can also affect cardiovascular risk and treatment access.

Family history changes risk; it does not make a particular event inevitable. Relatives can share multiple genetic variants as well as environments, stressors, health-care access, and learned responses to symptoms. The absence of a known family history does not exclude CAD, and the presence of one does not identify the exact artery that will be affected.

Physical activity can support cardiovascular health, but illness or disability does not reduce to inactivity, and exercise is not equally available or safe for every person. Risk assessment for wheelchair users and people with chronic illness should consider blood pressure, lipids, glucose, sleep, medication effects, autonomic function, family history, and accessible forms of activity without treating disability itself as a behavioral failure.

Presentation

Stable angina commonly appears with exertion or emotional stress and improves with rest or prescribed medication. It may feel like pressure, squeezing, heaviness, tightness, burning, or discomfort in the chest. Symptoms can also involve the shoulders, arms, neck, jaw, back, or upper abdomen. Shortness of breath, unusual fatigue, nausea, sweating, weakness, or dizziness may occur with or without recognizable chest pain.

CAD can be silent. Diabetes and some neurological conditions can alter pain or autonomic sensation, but symptom variation occurs across all populations. Sex, age, race, disability, calm presentation, and the ability to continue speaking or working are not reliable grounds for dismissing a possible cardiac symptom.

New chest discomfort at rest, symptoms that are more frequent or severe than a person’s usual pattern, unexplained shortness of breath, fainting, or symptoms suggestive of myocardial infarction require urgent assessment. A person should not be expected to determine at home whether the cause is CAD, pulmonary embolism, aortic disease, reflux, musculoskeletal pain, panic, autonomic dysfunction, or another condition.

Diagnosis

Evaluation begins with the symptom history, prior conditions, medication use, family history, blood pressure, and cardiovascular risk. Clinicians may use an electrocardiogram, blood tests, echocardiography, or other testing to evaluate current symptoms and competing diagnoses. Lipid and glucose testing help identify treatable risk factors.

Testing for chronic CAD can include:

  • Coronary artery calcium scoring, which uses CT to identify calcified plaque and can refine risk estimates in selected asymptomatic adults.
  • Exercise stress testing, which evaluates cardiac response to increasing workload when a person can exercise safely and the result will answer the clinical question.
  • Pharmacological stress testing, which uses medication rather than treadmill or bicycle exercise and can be paired with echocardiography, nuclear imaging, MRI, or PET.
  • Coronary CT angiography, which provides noninvasive images of the coronary arteries.
  • Invasive coronary angiography, which uses a catheter and contrast material to define coronary anatomy and can lead directly to an intervention when appropriate.

No single test is correct for every person. A nondiagnostic or normal result on one study does not erase persistent symptoms, and an anatomical narrowing does not by itself determine how much it limits blood flow or which treatment best fits the person.

Treatment and Management

Management is individualized through shared decision-making. It can include treatment of blood pressure, diabetes, and sleep apnea; smoking cessation support; nutrition and activity changes that are feasible for the person’s body and circumstances; and medication to lower LDL cholesterol, reduce clotting risk, or control angina. Statins remain first-line lipid-lowering treatment for most people with chronic coronary disease, while antiplatelet, beta-blocker, calcium-channel blocker, nitrate, and other therapies depend on the clinical situation.

Percutaneous coronary intervention uses a catheter to open a narrowed or occluded artery, usually with balloon dilation and a stent. It is central to treatment of many acute coronary syndromes and can improve persistent lifestyle-limiting angina when medication is insufficient and the anatomy is suitable. Coronary artery bypass grafting routes blood around diseased vessels and may be preferred for left-main disease, complex multivessel disease, or other high-risk anatomy. Neither procedure removes atherosclerosis from the rest of the arterial system, so long-term preventive care continues afterward.

Cardiac rehabilitation combines supervised and adapted activity, medication and risk-factor support, education, and psychological care. Programs must accommodate wheelchair use, sensory access, communication needs, fatigue, pain, and transportation. Upper-body ergometry, functional electrical stimulation, recumbent equipment, or individually monitored movement may substitute for treadmill-based assumptions when clinically appropriate.

Course and Complications

CAD may remain stable for long periods or progress despite appropriate care. An acute coronary syndrome includes unstable angina and myocardial infarction. Plaque disruption and clot formation can sharply reduce blood flow, producing a STEMI or NSTEMI according to the electrical and laboratory pattern rather than a simple percentage-of-blockage scale.

Complications include arrhythmia, impaired ventricular function, heart failure, cardiogenic shock, cardiac arrest, recurrent ischemia, medication adverse effects, and disability after an infarction or procedure. Prognosis depends on the amount and location of threatened myocardium, speed of reperfusion, baseline heart and kidney function, co-occurring conditions, access to emergency care, and rehabilitation—not merely on whether someone appeared healthy beforehand.

Historical Context

Clinical recognition of angina predates the ability to image coronary arteries or restore blood flow. Coronary angiography became practical in the mid-twentieth century and made arterial anatomy visible. Coronary bypass surgery, catheter-based angioplasty, stents, antiplatelet treatment, statins, cardiac biomarkers, and organized rehabilitation successively expanded both acute and chronic care.

Modern treatment has made severe CAD survivable for many people, but outcomes remain unequal. Delayed recognition, inaccessible testing and rehabilitation, medication cost, geography, racial bias, disability bias, and inconsistent emergency access can all determine who receives timely diagnosis and treatment.

Associated Characters

Nathan Weston

Nathan was diagnosed with early-stage coronary artery disease and chronic hypertension in 2020, when he was forty-seven and Logan was twelve. Fatigue, reduced running capacity, severe hypertension, nausea, chest discomfort, and shortness of breath formed part of his cardiac history.

In 2023, at age fifty, Nathan experienced unstable angina while working at the Baltimore Police Department. Evaluation showed concerning LAD narrowing, and he spent several months on restricted duty. He received ongoing medical care, but he also had an established habit of minimizing symptoms and attributing changes to his knees, back, work, or age. That minimization affected what he told his family and clinicians; it does not provide a single sufficient explanation for the later progression of his disease.

Nathan died in 2053, after his eightieth birthday, from a massive myocardial infarction caused by complete LAD occlusion. His father had heart disease, and his paternal grandfather had died from a fatal LAD event. Nathan’s death therefore continued an established family history without making the same outcome inevitable for every relative.

Logan Weston

Logan’s family history, Type 1 diabetes, and the obstructive component of his mixed sleep apnea were clinically relevant to his cardiovascular risk. His father’s death occurred in 2053, five years before Logan’s own cardiac emergency.

In 2058, at age fifty, Logan survived a myocardial infarction caused by complete LAD occlusion and underwent emergency coronary artery bypass grafting. The event left lasting cardiac damage and changed his capacity in later life. Continued management included cardiac rehabilitation, risk-factor care, and PAP treatment for his mixed central and obstructive sleep apnea. His survival differed from Nathan’s outcome without establishing medical vigilance, personality, or technology as the sole reason for that difference.

Accessibility and Medical-System Context

Cardiac symptoms can overlap with chronic pain, fatigue, reflux, panic, dysautonomia, respiratory illness, medication effects, or neurological changes. Overlap calls for careful assessment rather than automatic attribution to a person’s existing disability. A baseline that already includes pain or autonomic symptoms makes a change from that baseline particularly important.

Wheelchair-accessible examination tables, scales, imaging equipment, catheterization transfer plans, and rehabilitation spaces affect whether care is genuinely available. A person who cannot use a treadmill may need pharmacological stress testing or another imaging pathway. Deaf, hard-of-hearing, nonspeaking, and cognitively fatigued patients may need interpreters, AAC, writing, additional processing time, or a familiar communication partner without surrendering their own decision-making authority.

Black patients and disabled patients can face delayed recognition when clinicians interpret symptoms through stereotypes about pain tolerance, age, fitness, anxiety, drug use, or compliance. Accurate care separates a person’s behavior from the biological course of atherosclerosis while still taking medication access, symptom reporting, occupational pressure, and prior medical harm seriously.

Sources

Medical Conditions Cardiovascular Conditions Chronic Conditions Nathan Weston Logan Weston